These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 15028670

  • 21. Causative role of oxidative stress in a Drosophila model of Friedreich ataxia.
    Llorens JV, Navarro JA, Martínez-Sebastián MJ, Baylies MK, Schneuwly S, Botella JA, Moltó MD.
    FASEB J; 2007 Feb; 21(2):333-44. PubMed ID: 17167074
    [Abstract] [Full Text] [Related]

  • 22. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F, Santos R, Planamente S, Lesuisse E, Camadro JM.
    Hum Mol Genet; 2008 Sep 15; 17(18):2790-802. PubMed ID: 18562474
    [Abstract] [Full Text] [Related]

  • 23. Deficiency of Arabidopsis thaliana frataxin alters activity of mitochondrial Fe-S proteins and induces oxidative stress.
    Busi MV, Maliandi MV, Valdez H, Clemente M, Zabaleta EJ, Araya A, Gomez-Casati DF.
    Plant J; 2006 Dec 15; 48(6):873-82. PubMed ID: 17092311
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recombinant human erythropoietin: effects on frataxin expression in vitro.
    Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, Scheiber-Mojdehkar B.
    Eur J Clin Invest; 2005 Nov 15; 35(11):711-7. PubMed ID: 16269021
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Primary and secondary drug screening assays for Friedreich ataxia.
    Cotticelli MG, Rasmussen L, Kushner NL, McKellip S, Sosa MI, Manouvakhova A, Feng S, White EL, Maddry JA, Heemskerk J, Oldt RJ, Surrey LF, Ochs R, Wilson RB.
    J Biomol Screen; 2012 Mar 15; 17(3):303-13. PubMed ID: 22086726
    [Abstract] [Full Text] [Related]

  • 28. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM.
    Arch Neurol; 2005 Apr 15; 62(4):621-6. PubMed ID: 15824263
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.
    Zhao H, Li H, Hao S, Chen J, Wu J, Song C, Zhang M, Qiao T, Li K.
    Sci Rep; 2017 Aug 29; 7(1):9840. PubMed ID: 28852135
    [Abstract] [Full Text] [Related]

  • 31. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
    Rustin P, Rötig A, Munnich A, Sidi D.
    Free Radic Res; 2002 Apr 29; 36(4):467-9. PubMed ID: 12069112
    [Abstract] [Full Text] [Related]

  • 32. Oxidative stress induces mitochondrial fragmentation in frataxin-deficient cells.
    Lefevre S, Sliwa D, Rustin P, Camadro JM, Santos R.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):336-41. PubMed ID: 22274609
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.
    Calmels N, Seznec H, Villa P, Reutenauer L, Hibert M, Haiech J, Rustin P, Koenig M, Puccio H.
    BMC Neurol; 2009 Aug 24; 9():46. PubMed ID: 19703283
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.